Willow Biosciences Inc.
Willow Biosciences Inc. (CANSF) Stock Competitors & Peer Comparison
See (CANSF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CANSF | $0.15 | +3.64% | 91.3M | -1.21 | -$0.12 | N/A |
| MKGAF | $127.15 | -3.52% | 56B | 16.93 | $7.61 | +1.93% |
| MKKGY | $25.18 | -1.22% | 55.5B | 16.53 | $1.52 | +1.98% |
| HLNCF | $4.89 | -2.20% | 43.9B | 23.29 | $0.21 | +1.74% |
| TKPHF | $27.50 | +0.55% | 43B | 59.78 | $0.46 | +4.87% |
| IPSEY | $30.42 | -7.82% | 40.3B | 24.53 | $1.24 | +0.81% |
| SDZNY | $57.01 | -3.09% | 24.6B | -2861.00 | -$0.02 | +1.17% |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| TEVJF | $14.00 | +0.00% | 16.1B | -93.33 | -$0.15 | N/A |
| SGIOF | $16.79 | +1.45% | 14.3B | 12.35 | $1.36 | +2.48% |
Stock Comparison
CANSF vs MKGAF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, MKGAF has a market cap of 56B. Regarding current trading prices, CANSF is priced at $0.15, while MKGAF trades at $127.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas MKGAF's P/E ratio is 16.93. In terms of profitability, CANSF's ROE is -21.00%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, CANSF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check MKGAF's competition here
CANSF vs MKKGY Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, MKKGY has a market cap of 55.5B. Regarding current trading prices, CANSF is priced at $0.15, while MKKGY trades at $25.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas MKKGY's P/E ratio is 16.53. In terms of profitability, CANSF's ROE is -21.00%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, CANSF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check MKKGY's competition here
CANSF vs HLNCF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, HLNCF has a market cap of 43.9B. Regarding current trading prices, CANSF is priced at $0.15, while HLNCF trades at $4.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas HLNCF's P/E ratio is 23.29. In terms of profitability, CANSF's ROE is -21.00%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, CANSF is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check HLNCF's competition here
CANSF vs TKPHF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, TKPHF has a market cap of 43B. Regarding current trading prices, CANSF is priced at $0.15, while TKPHF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas TKPHF's P/E ratio is 59.78. In terms of profitability, CANSF's ROE is -21.00%, compared to TKPHF's ROE of +0.01%. Regarding short-term risk, CANSF and TKPHF have similar daily volatility (0.00).Check TKPHF's competition here
CANSF vs IPSEY Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, IPSEY has a market cap of 40.3B. Regarding current trading prices, CANSF is priced at $0.15, while IPSEY trades at $30.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas IPSEY's P/E ratio is 24.53. In terms of profitability, CANSF's ROE is -21.00%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, CANSF and IPSEY have similar daily volatility (0.00).Check IPSEY's competition here
CANSF vs SDZNY Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, SDZNY has a market cap of 24.6B. Regarding current trading prices, CANSF is priced at $0.15, while SDZNY trades at $57.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas SDZNY's P/E ratio is -2861.00. In terms of profitability, CANSF's ROE is -21.00%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, CANSF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check SDZNY's competition here
CANSF vs ESALY Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, CANSF is priced at $0.15, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas ESALY's P/E ratio is 20.54. In terms of profitability, CANSF's ROE is -21.00%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, CANSF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check ESALY's competition here
CANSF vs TEVJF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, TEVJF has a market cap of 16.1B. Regarding current trading prices, CANSF is priced at $0.15, while TEVJF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas TEVJF's P/E ratio is -93.33. In terms of profitability, CANSF's ROE is -21.00%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, CANSF is less volatile compared to TEVJF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check TEVJF's competition here
CANSF vs SGIOF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, SGIOF has a market cap of 14.3B. Regarding current trading prices, CANSF is priced at $0.15, while SGIOF trades at $16.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas SGIOF's P/E ratio is 12.35. In terms of profitability, CANSF's ROE is -21.00%, compared to SGIOF's ROE of +0.05%. Regarding short-term risk, CANSF and SGIOF have similar daily volatility (0.00).Check SGIOF's competition here
CANSF vs SGIOY Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, SGIOY has a market cap of 14.2B. Regarding current trading prices, CANSF is priced at $0.15, while SGIOY trades at $8.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas SGIOY's P/E ratio is 12.42. In terms of profitability, CANSF's ROE is -21.00%, compared to SGIOY's ROE of +0.05%. Regarding short-term risk, CANSF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check SGIOY's competition here
CANSF vs BIOVF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, BIOVF has a market cap of 10.3B. Regarding current trading prices, CANSF is priced at $0.15, while BIOVF trades at $29.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas BIOVF's P/E ratio is 22.40. In terms of profitability, CANSF's ROE is -21.00%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, CANSF and BIOVF have similar daily volatility (0.00).Check BIOVF's competition here
CANSF vs SFOSF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, SFOSF has a market cap of 10.2B. Regarding current trading prices, CANSF is priced at $0.15, while SFOSF trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas SFOSF's P/E ratio is 17.80. In terms of profitability, CANSF's ROE is -21.00%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, CANSF is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check SFOSF's competition here
CANSF vs IPSEF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, CANSF is priced at $0.15, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas IPSEF's P/E ratio is 22.81. In terms of profitability, CANSF's ROE is -21.00%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, CANSF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check IPSEF's competition here
CANSF vs ESAIY Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, ESAIY has a market cap of 8.1B. Regarding current trading prices, CANSF is priced at $0.15, while ESAIY trades at $7.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas ESAIY's P/E ratio is 25.31. In terms of profitability, CANSF's ROE is -21.00%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, CANSF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check ESAIY's competition here
CANSF vs ESALF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, ESALF has a market cap of 7.8B. Regarding current trading prices, CANSF is priced at $0.15, while ESALF trades at $27.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas ESALF's P/E ratio is 25.01. In terms of profitability, CANSF's ROE is -21.00%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, CANSF and ESALF have similar daily volatility (0.00).Check ESALF's competition here
CANSF vs HKMPY Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, HKMPY has a market cap of 5.9B. Regarding current trading prices, CANSF is priced at $0.15, while HKMPY trades at $53.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas HKMPY's P/E ratio is 16.54. In terms of profitability, CANSF's ROE is -21.00%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, CANSF and HKMPY have similar daily volatility (0.00).Check HKMPY's competition here
CANSF vs GZPHF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, GZPHF has a market cap of 5.8B. Regarding current trading prices, CANSF is priced at $0.15, while GZPHF trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas GZPHF's P/E ratio is 10.22. In terms of profitability, CANSF's ROE is -21.00%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, CANSF is less volatile compared to GZPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check GZPHF's competition here
CANSF vs HKMPF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, HKMPF has a market cap of 5.8B. Regarding current trading prices, CANSF is priced at $0.15, while HKMPF trades at $26.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas HKMPF's P/E ratio is 16.38. In terms of profitability, CANSF's ROE is -21.00%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, CANSF and HKMPF have similar daily volatility (0.00).Check HKMPF's competition here
CANSF vs SGFEF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, CANSF is priced at $0.15, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas SGFEF's P/E ratio is 24.70. In terms of profitability, CANSF's ROE is -21.00%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, CANSF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check SGFEF's competition here
CANSF vs WIBFF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, CANSF is priced at $0.15, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, CANSF's ROE is -21.00%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, CANSF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check WIBFF's competition here
CANSF vs HLUBF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, HLUBF has a market cap of 4.4B. Regarding current trading prices, CANSF is priced at $0.15, while HLUBF trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas HLUBF's P/E ratio is 9.13. In terms of profitability, CANSF's ROE is -21.00%, compared to HLUBF's ROE of +0.14%. Regarding short-term risk, CANSF is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check HLUBF's competition here
CANSF vs HLBBF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, HLBBF has a market cap of 4.1B. Regarding current trading prices, CANSF is priced at $0.15, while HLBBF trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas HLBBF's P/E ratio is 9.90. In terms of profitability, CANSF's ROE is -21.00%, compared to HLBBF's ROE of +0.14%. Regarding short-term risk, CANSF is less volatile compared to HLBBF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check HLBBF's competition here
CANSF vs SMDPY Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, SMDPY has a market cap of 3.9B. Regarding current trading prices, CANSF is priced at $0.15, while SMDPY trades at $9.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas SMDPY's P/E ratio is 24.48. In terms of profitability, CANSF's ROE is -21.00%, compared to SMDPY's ROE of +0.15%. Regarding short-term risk, CANSF and SMDPY have similar daily volatility (0.00).Check SMDPY's competition here
CANSF vs CHSYF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, CHSYF has a market cap of 3.7B. Regarding current trading prices, CANSF is priced at $0.15, while CHSYF trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas CHSYF's P/E ratio is 16.85. In terms of profitability, CANSF's ROE is -21.00%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, CANSF is less volatile compared to CHSYF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check CHSYF's competition here
CANSF vs LVZPF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, LVZPF has a market cap of 3.5B. Regarding current trading prices, CANSF is priced at $0.15, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, CANSF's ROE is -21.00%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, CANSF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check LVZPF's competition here
CANSF vs ULIHF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, ULIHF has a market cap of 3.2B. Regarding current trading prices, CANSF is priced at $0.15, while ULIHF trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas ULIHF's P/E ratio is 8.20. In terms of profitability, CANSF's ROE is -21.00%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, CANSF is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check ULIHF's competition here
CANSF vs APNHF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, CANSF is priced at $0.15, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas APNHF's P/E ratio is 12.72. In terms of profitability, CANSF's ROE is -21.00%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, CANSF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check APNHF's competition here
CANSF vs APNHY Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, APNHY has a market cap of 3B. Regarding current trading prices, CANSF is priced at $0.15, while APNHY trades at $6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas APNHY's P/E ratio is 11.93. In terms of profitability, CANSF's ROE is -21.00%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, CANSF is less volatile compared to APNHY. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check APNHY's competition here
CANSF vs INVVY Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, CANSF is priced at $0.15, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas INVVY's P/E ratio is -62.42. In terms of profitability, CANSF's ROE is -21.00%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, CANSF and INVVY have similar daily volatility (0.00).Check INVVY's competition here
CANSF vs HYPMY Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, HYPMY has a market cap of 3B. Regarding current trading prices, CANSF is priced at $0.15, while HYPMY trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas HYPMY's P/E ratio is 20.50. In terms of profitability, CANSF's ROE is -21.00%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, CANSF and HYPMY have similar daily volatility (0.00).Check HYPMY's competition here
CANSF vs IZQVF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, CANSF is priced at $0.15, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, CANSF's ROE is -21.00%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, CANSF and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
CANSF vs DNPUF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, DNPUF has a market cap of 2.9B. Regarding current trading prices, CANSF is priced at $0.15, while DNPUF trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas DNPUF's P/E ratio is 18.10. In terms of profitability, CANSF's ROE is -21.00%, compared to DNPUF's ROE of +0.15%. Regarding short-term risk, CANSF is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check DNPUF's competition here
CANSF vs LBTSF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, CANSF is priced at $0.15, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas LBTSF's P/E ratio is 111.33. In terms of profitability, CANSF's ROE is -21.00%, compared to LBTSF's ROE of +0.02%. Regarding short-term risk, CANSF is less volatile compared to LBTSF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check LBTSF's competition here
CANSF vs HMDCF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, CANSF is priced at $0.15, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, CANSF's ROE is -21.00%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, CANSF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check HMDCF's competition here
CANSF vs THCBF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, CANSF is priced at $0.15, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas THCBF's P/E ratio is -0.10. In terms of profitability, CANSF's ROE is -21.00%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, CANSF is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check THCBF's competition here
CANSF vs DMPHF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, CANSF is priced at $0.15, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, CANSF's ROE is -21.00%, compared to DMPHF's ROE of +0.17%. Regarding short-term risk, CANSF and DMPHF have similar daily volatility (0.00).Check DMPHF's competition here
CANSF vs HTSUF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, CANSF is priced at $0.15, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas HTSUF's P/E ratio is 16.08. In terms of profitability, CANSF's ROE is -21.00%, compared to HTSUF's ROE of +0.08%. Regarding short-term risk, CANSF is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check HTSUF's competition here
CANSF vs LJUIF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, CANSF is priced at $0.15, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, CANSF's ROE is -21.00%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, CANSF and LJUIF have similar daily volatility (0.00).Check LJUIF's competition here
CANSF vs ARSUF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, CANSF is priced at $0.15, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, CANSF's ROE is -21.00%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, CANSF and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here
CANSF vs TSMRF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, CANSF is priced at $0.15, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas TSMRF's P/E ratio is 8.24. In terms of profitability, CANSF's ROE is -21.00%, compared to TSMRF's ROE of +0.11%. Regarding short-term risk, CANSF is less volatile compared to TSMRF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check TSMRF's competition here
CANSF vs YIHCF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, YIHCF has a market cap of 1.8B. Regarding current trading prices, CANSF is priced at $0.15, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, CANSF's ROE is -21.00%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, CANSF and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
CANSF vs NPNKF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, CANSF is priced at $0.15, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas NPNKF's P/E ratio is 7.87. In terms of profitability, CANSF's ROE is -21.00%, compared to NPNKF's ROE of +0.14%. Regarding short-term risk, CANSF is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check NPNKF's competition here
CANSF vs CASBF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, CASBF has a market cap of 1.6B. Regarding current trading prices, CANSF is priced at $0.15, while CASBF trades at $5.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas CASBF's P/E ratio is -25.33. In terms of profitability, CANSF's ROE is -21.00%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, CANSF and CASBF have similar daily volatility (0.00).Check CASBF's competition here
CANSF vs MITPF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, CANSF is priced at $0.15, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas MITPF's P/E ratio is -10.81. In terms of profitability, CANSF's ROE is -21.00%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, CANSF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check MITPF's competition here
CANSF vs KARBF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, CANSF is priced at $0.15, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas KARBF's P/E ratio is 262.50. In terms of profitability, CANSF's ROE is -21.00%, compared to KARBF's ROE of N/A. Regarding short-term risk, CANSF and KARBF have similar daily volatility (0.00).Check KARBF's competition here
CANSF vs EVOTF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, CANSF is priced at $0.15, while EVOTF trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas EVOTF's P/E ratio is -6.17. In terms of profitability, CANSF's ROE is -21.00%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, CANSF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check EVOTF's competition here
CANSF vs NPPNY Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, CANSF is priced at $0.15, while NPPNY trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas NPPNY's P/E ratio is 6.52. In terms of profitability, CANSF's ROE is -21.00%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, CANSF and NPPNY have similar daily volatility (0.00).Check NPPNY's competition here
CANSF vs GTBIF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, GTBIF has a market cap of 1.4B. Regarding current trading prices, CANSF is priced at $0.15, while GTBIF trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas GTBIF's P/E ratio is 27.90. In terms of profitability, CANSF's ROE is -21.00%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, CANSF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check GTBIF's competition here
CANSF vs CHIZF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, CANSF is priced at $0.15, while CHIZF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas CHIZF's P/E ratio is 13.75. In terms of profitability, CANSF's ROE is -21.00%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, CANSF and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
CANSF vs SHEZF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, SHEZF has a market cap of 1.4B. Regarding current trading prices, CANSF is priced at $0.15, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, CANSF's ROE is -21.00%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, CANSF is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check SHEZF's competition here
CANSF vs GNMLF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, CANSF is priced at $0.15, while GNMLF trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas GNMLF's P/E ratio is 11.70. In terms of profitability, CANSF's ROE is -21.00%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, CANSF and GNMLF have similar daily volatility (0.00).Check GNMLF's competition here
CANSF vs SWGHF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, CANSF is priced at $0.15, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, CANSF's ROE is -21.00%, compared to SWGHF's ROE of +0.12%. Regarding short-term risk, CANSF and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
CANSF vs KSPHF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, CANSF is priced at $0.15, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas KSPHF's P/E ratio is 14.66. In terms of profitability, CANSF's ROE is -21.00%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, CANSF is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check KSPHF's competition here
CANSF vs CURLF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, CURLF has a market cap of 1B. Regarding current trading prices, CANSF is priced at $0.15, while CURLF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas CURLF's P/E ratio is -4.12. In terms of profitability, CANSF's ROE is -21.00%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, CANSF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check CURLF's competition here
CANSF vs KKPCF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, CANSF is priced at $0.15, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas KKPCF's P/E ratio is 11.24. In terms of profitability, CANSF's ROE is -21.00%, compared to KKPCF's ROE of +0.09%. Regarding short-term risk, CANSF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check KKPCF's competition here
CANSF vs BIOGY Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, BIOGY has a market cap of 960.3M. Regarding current trading prices, CANSF is priced at $0.15, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas BIOGY's P/E ratio is 32.50. In terms of profitability, CANSF's ROE is -21.00%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, CANSF and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
CANSF vs SHPHF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, CANSF is priced at $0.15, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, CANSF's ROE is -21.00%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, CANSF is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check SHPHF's competition here
CANSF vs LVTTF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, LVTTF has a market cap of 891.2M. Regarding current trading prices, CANSF is priced at $0.15, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, CANSF's ROE is -21.00%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, CANSF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check LVTTF's competition here
CANSF vs EVRRF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, EVRRF has a market cap of 887.4M. Regarding current trading prices, CANSF is priced at $0.15, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, CANSF's ROE is -21.00%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, CANSF and EVRRF have similar daily volatility (0.00).Check EVRRF's competition here
CANSF vs TCNNF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, TCNNF has a market cap of 840.7M. Regarding current trading prices, CANSF is priced at $0.15, while TCNNF trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas TCNNF's P/E ratio is -5.57. In terms of profitability, CANSF's ROE is -21.00%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, CANSF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check TCNNF's competition here
CANSF vs NRXCF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, NRXCF has a market cap of 838.3M. Regarding current trading prices, CANSF is priced at $0.15, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, CANSF's ROE is -21.00%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, CANSF and NRXCF have similar daily volatility (0.00).Check NRXCF's competition here
CANSF vs TWAPF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, CANSF is priced at $0.15, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, CANSF's ROE is -21.00%, compared to TWAPF's ROE of +0.11%. Regarding short-term risk, CANSF is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check TWAPF's competition here
CANSF vs SWDCF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, SWDCF has a market cap of 773.6M. Regarding current trading prices, CANSF is priced at $0.15, while SWDCF trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas SWDCF's P/E ratio is 121.00. In terms of profitability, CANSF's ROE is -21.00%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, CANSF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check SWDCF's competition here
CANSF vs CSWYF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, CANSF is priced at $0.15, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, CANSF's ROE is -21.00%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, CANSF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check CSWYF's competition here
CANSF vs TRXPF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, CANSF is priced at $0.15, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, CANSF's ROE is -21.00%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, CANSF and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
CANSF vs TRSSF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, CANSF is priced at $0.15, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, CANSF's ROE is -21.00%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, CANSF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check TRSSF's competition here
CANSF vs ELTP Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, ELTP has a market cap of 546.1M. Regarding current trading prices, CANSF is priced at $0.15, while ELTP trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas ELTP's P/E ratio is -25.50. In terms of profitability, CANSF's ROE is -21.00%, compared to ELTP's ROE of -0.09%. Regarding short-term risk, CANSF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check ELTP's competition here
CANSF vs AIHLF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, AIHLF has a market cap of 543.1M. Regarding current trading prices, CANSF is priced at $0.15, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas AIHLF's P/E ratio is 12.50. In terms of profitability, CANSF's ROE is -21.00%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, CANSF and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
CANSF vs PKBFF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, PKBFF has a market cap of 542M. Regarding current trading prices, CANSF is priced at $0.15, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas PKBFF's P/E ratio is N/A. In terms of profitability, CANSF's ROE is -21.00%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, CANSF and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
CANSF vs CCHWF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, CANSF is priced at $0.15, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, CANSF's ROE is -21.00%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, CANSF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check CCHWF's competition here
CANSF vs BOIRF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, CANSF is priced at $0.15, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, CANSF's ROE is -21.00%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, CANSF is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check BOIRF's competition here
CANSF vs PEXXF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, CANSF is priced at $0.15, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, CANSF's ROE is -21.00%, compared to PEXXF's ROE of N/A. Regarding short-term risk, CANSF and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
CANSF vs KHTRF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, KHTRF has a market cap of 446.4M. Regarding current trading prices, CANSF is priced at $0.15, while KHTRF trades at $4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas KHTRF's P/E ratio is 64.00. In terms of profitability, CANSF's ROE is -21.00%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, CANSF is less volatile compared to KHTRF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check KHTRF's competition here
CANSF vs AGYTF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, CANSF is priced at $0.15, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, CANSF's ROE is -21.00%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, CANSF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check AGYTF's competition here
CANSF vs HUMDF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, CANSF is priced at $0.15, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, CANSF's ROE is -21.00%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, CANSF and HUMDF have similar daily volatility (0.00).Check HUMDF's competition here
CANSF vs NIKA Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, NIKA has a market cap of 366.9M. Regarding current trading prices, CANSF is priced at $0.15, while NIKA trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas NIKA's P/E ratio is N/A. In terms of profitability, CANSF's ROE is -21.00%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, CANSF is less volatile compared to NIKA. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check NIKA's competition here
CANSF vs BHCCF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, BHCCF has a market cap of 271.6M. Regarding current trading prices, CANSF is priced at $0.15, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, CANSF's ROE is -21.00%, compared to BHCCF's ROE of +0.19%. Regarding short-term risk, CANSF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check BHCCF's competition here
CANSF vs GLASF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, GLASF has a market cap of 263.9M. Regarding current trading prices, CANSF is priced at $0.15, while GLASF trades at $5.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas GLASF's P/E ratio is -56.44. In terms of profitability, CANSF's ROE is -21.00%, compared to GLASF's ROE of +0.07%. Regarding short-term risk, CANSF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check GLASF's competition here
CANSF vs CPHRF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, CPHRF has a market cap of 223.7M. Regarding current trading prices, CANSF is priced at $0.15, while CPHRF trades at $8.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas CPHRF's P/E ratio is 24.25. In terms of profitability, CANSF's ROE is -21.00%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, CANSF is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check CPHRF's competition here
CANSF vs VRNOF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, VRNOF has a market cap of 210.9M. Regarding current trading prices, CANSF is priced at $0.15, while VRNOF trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas VRNOF's P/E ratio is -0.59. In terms of profitability, CANSF's ROE is -21.00%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, CANSF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check VRNOF's competition here
CANSF vs CRLBF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, CRLBF has a market cap of 204.9M. Regarding current trading prices, CANSF is priced at $0.15, while CRLBF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas CRLBF's P/E ratio is -2.53. In terms of profitability, CANSF's ROE is -21.00%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, CANSF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check CRLBF's competition here
CANSF vs PLNHF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, CANSF is priced at $0.15, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, CANSF's ROE is -21.00%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, CANSF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check PLNHF's competition here
CANSF vs PHCUF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, PHCUF has a market cap of 159.9M. Regarding current trading prices, CANSF is priced at $0.15, while PHCUF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas PHCUF's P/E ratio is 600.00. In terms of profitability, CANSF's ROE is -21.00%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, CANSF and PHCUF have similar daily volatility (0.00).Check PHCUF's competition here
CANSF vs COPHF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, CANSF is priced at $0.15, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas COPHF's P/E ratio is -0.02. In terms of profitability, CANSF's ROE is -21.00%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, CANSF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check COPHF's competition here
CANSF vs CBWTF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, CBWTF has a market cap of 128.9M. Regarding current trading prices, CANSF is priced at $0.15, while CBWTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas CBWTF's P/E ratio is 4.83. In terms of profitability, CANSF's ROE is -21.00%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, CANSF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check CBWTF's competition here
CANSF vs STMH Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, STMH has a market cap of 125.9M. Regarding current trading prices, CANSF is priced at $0.15, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas STMH's P/E ratio is N/A. In terms of profitability, CANSF's ROE is -21.00%, compared to STMH's ROE of -2.75%. Regarding short-term risk, CANSF is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check STMH's competition here
CANSF vs NWPN Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, CANSF is priced at $0.15, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas NWPN's P/E ratio is -0.04. In terms of profitability, CANSF's ROE is -21.00%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, CANSF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check NWPN's competition here
CANSF vs LOVFF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, LOVFF has a market cap of 122.5M. Regarding current trading prices, CANSF is priced at $0.15, while LOVFF trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas LOVFF's P/E ratio is 13.40. In terms of profitability, CANSF's ROE is -21.00%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, CANSF and LOVFF have similar daily volatility (0.00).Check LOVFF's competition here
CANSF vs HLTRF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, HLTRF has a market cap of 116.5M. Regarding current trading prices, CANSF is priced at $0.15, while HLTRF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas HLTRF's P/E ratio is -6.49. In terms of profitability, CANSF's ROE is -21.00%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, CANSF and HLTRF have similar daily volatility (0.00).Check HLTRF's competition here
CANSF vs LPCUF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, CANSF is priced at $0.15, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, CANSF's ROE is -21.00%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, CANSF and LPCUF have similar daily volatility (0.00).Check LPCUF's competition here
CANSF vs JUSHF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, JUSHF has a market cap of 110.7M. Regarding current trading prices, CANSF is priced at $0.15, while JUSHF trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas JUSHF's P/E ratio is -2.25. In terms of profitability, CANSF's ROE is -21.00%, compared to JUSHF's ROE of +1.06%. Regarding short-term risk, CANSF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check JUSHF's competition here
CANSF vs CNVCF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, CANSF is priced at $0.15, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, CANSF's ROE is -21.00%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, CANSF and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here
CANSF vs GRUSF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, GRUSF has a market cap of 95.2M. Regarding current trading prices, CANSF is priced at $0.15, while GRUSF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas GRUSF's P/E ratio is -12.80. In terms of profitability, CANSF's ROE is -21.00%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, CANSF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check GRUSF's competition here
CANSF vs BIOYF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, BIOYF has a market cap of 93.7M. Regarding current trading prices, CANSF is priced at $0.15, while BIOYF trades at $8.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas BIOYF's P/E ratio is 16.67. In terms of profitability, CANSF's ROE is -21.00%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, CANSF is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check BIOYF's competition here
CANSF vs LRDSF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, LRDSF has a market cap of 83.9M. Regarding current trading prices, CANSF is priced at $0.15, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, CANSF's ROE is -21.00%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, CANSF is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check LRDSF's competition here
CANSF vs AAWH Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, AAWH has a market cap of 79.7M. Regarding current trading prices, CANSF is priced at $0.15, while AAWH trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas AAWH's P/E ratio is -0.97. In terms of profitability, CANSF's ROE is -21.00%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, CANSF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check AAWH's competition here
CANSF vs ABSCF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, ABSCF has a market cap of 77.4M. Regarding current trading prices, CANSF is priced at $0.15, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas ABSCF's P/E ratio is -7.00. In terms of profitability, CANSF's ROE is -21.00%, compared to ABSCF's ROE of +0.32%. Regarding short-term risk, CANSF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check ABSCF's competition here
CANSF vs EOFBY Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, CANSF is priced at $0.15, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, CANSF's ROE is -21.00%, compared to EOFBY's ROE of N/A. Regarding short-term risk, CANSF and EOFBY have similar daily volatility (0.00).Check EOFBY's competition here
CANSF vs ORXOF Comparison August 2025
CANSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANSF stands at 91.3M. In comparison, ORXOF has a market cap of 69.7M. Regarding current trading prices, CANSF is priced at $0.15, while ORXOF trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANSF currently has a P/E ratio of -1.21, whereas ORXOF's P/E ratio is -3.11. In terms of profitability, CANSF's ROE is -21.00%, compared to ORXOF's ROE of +2.89%. Regarding short-term risk, CANSF is less volatile compared to ORXOF. This indicates potentially lower risk in terms of short-term price fluctuations for CANSF.Check ORXOF's competition here